Novartis India Ltd.
|BSE: 500672||Sector: Health care|
|NSE: NOVARTIND||ISIN Code: INE234A01025|
|BSE 12:37 | 22 Jan||663.00||
|NSE 05:30 | 01 Jan||Stock Is Not Traded.|
|Mkt Cap.(Rs cr)||1,866|
|Mkt Cap.(Rs cr)||1865.68|
Novartis India Ltd. (NOVARTIND) - Latest News & Headlines
12.58 am | 14 Nov 2017 | Business Standard
The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and se...
5.04 pm | 25 Sep 2017 | Press Trust of India
Shares of Novartis India were trading 6.85% down at Rs 635.85 apiece on BSE
2.36 pm | 25 Sep 2017 | Business Standard
The board approved share buyback at a price of Rs 670 per share, against Friday's close of Rs 683 on BSE.
9.54 am | 21 Sep 2017 | Business Standard
So far in 2017, the stock under-performed the market by falling 24% as compared to 22% rise in the S&P BSE Sensex till Wednesday.
12.48 am | 5 Sep 2017 | Business Standard
At present, he holds the post of global head of drug development and chief medical officer
2.01 am | 1 Sep 2017 | Bloomberg
Novartis's arrangement to pay only if patients respond to the drug as a huge breakthrough